Cargando…

PUS1 May Be a Potential Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma

OBJECTIVE: The mechanisms of pseudouridine synthase (PUS) are not definite in hepatocellular carcinoma (HCC), the objective of this study is to investigate the effect of PUS genes in HCC. MATERIALS AND METHODS: Differentially expressed and prognostic gene of PUS enzymes was identified based on The C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lan, Chenlu, Huang, Xinlei, Liao, Xiwen, Zhou, Xin, Peng, Kai, Wei, Yongguang, Han, Chuangye, Peng, Tao, Wang, Jianyao, Zhu, Guangzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115212/ https://www.ncbi.nlm.nih.gov/pubmed/37091827 http://dx.doi.org/10.2147/PGPM.S405621

Ejemplares similares

Robust analysis of a novel PANoptosis-related prognostic gene signature model for hepatocellular carcinoma immune infiltration and therapeutic response
por: Wei, Yongguang, et al.
Publicado: (2023)

RAD51AP1 as an Immune-Related Prognostic Biomarker and Therapeutic Response Predictor in Hepatocellular Carcinoma
por: Wei, Yongguang, et al.
Publicado: (2023)

Outer dynein arm docking complex subunit 2 polymorphism rs7893462 modulates hepatocellular carcinoma susceptibility and can serve as an overall survival biomarker for hepatitis B virus-related hepatocellular carcinoma after hepatectomy: a cohort study with a long-term follow-up
por: Zeng, Zhiming, et al.
Publicado: (2023)

Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma
por: Liao, Xiwen, et al.
Publicado: (2018)

SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma
por: Nong, Jusen, et al.
Publicado: (2023)

The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinoma
por: Yu, Tingdong, et al.
Publicado: (2018)

The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2018)

Cystatin F as a key family 2 cystatin subunit and prognostic biomarker for early-stage pancreatic ductal adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019)

Acyl-CoA Binding Domain Containing 4 Polymorphism rs4986172 and Expression Can Serve as Overall Survival Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After Hepatectomy
por: Huang, Huasheng, et al.
Publicado: (2022)

Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
por: Liao, Xiwen, et al.
Publicado: (2018)

Diagnostic and prognostic value of mRNA expression of phospholipase C β family genes in hepatitis B virus-associated hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2019)

Identification of prognostic biomarkers for patients withhepatocellular carcinoma after hepatectomy
por: Wang, Xiangkun, et al.
Publicado: (2019)

NLRC and NLRX gene family mRNA expression and prognostic value in hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2017)

Distinct Diagnostic and Prognostic Values of Minichromosome Maintenance Gene Expression in Patients with Hepatocellular Carcinoma
por: Liao, Xiwen, et al.
Publicado: (2018)

Molecular mechanism of CK19 involved in the regulation of postoperative recurrence of HBV-associated primary hepatocellular carcinoma in Guangxi
por: Su, Hao, et al.
Publicado: (2021)

Clustered microRNAs hsa-miR-221-3p/hsa-miR-222-3p and their targeted genes might be prognostic predictors for hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2019)

Integrated analysis of competing endogenous RNA network revealing potential prognostic biomarkers of hepatocellular carcinoma
por: Liao, Xiwen, et al.
Publicado: (2019)

Prognostic value and potential molecular mechanism of the like-Sm gene family in early-stage pancreatic ductal adenocarcinoma
por: Chen, Zijun, et al.
Publicado: (2021)

Genetic variants in the exon region of versican predict survival of patients with resected early-stage hepatitis B virus-associated hepatocellular carcinoma
por: Liu, Xiaoguang, et al.
Publicado: (2018)

A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma
por: Xie, Hui, et al.
Publicado: (2020)

Diagnostic and prognostic value of WNT family gene expression in hepatitis B virus-related hepatocellular carcinoma
por: Han, Quanfa, et al.
Publicado: (2019)

Genome-wide association pathway analysis to identify candidate single nucleotide polymorphisms and molecular pathways associated with TP53 expression status in HBV-related hepatocellular carcinoma
por: Liao, Xiwen, et al.
Publicado: (2018)

Pus Inoculations
por: Nesfield, V.
Publicado: (1914)

Origin of Pus
por: Patrick, J. B.
Publicado: (1892)

Wanderings of Pus
por: Harvey, Leon F.
Publicado: (1866)

Pus in the Pelvis
por: Hayd, Herman E.
Publicado: (1899)

Pus Formation
Publicado: (1887)

Pus Dyscrasia
por: Barrett, W. C.
Publicado: (1881)

What Pus Is Not
por: Curtis, Lester
Publicado: (1874)

Establishment of a prognostic model for predicting short-term disease-free survival in cases of hepatitis B-related hepatocellular carcinoma with the TP53 249Ser mutation in southern China
por: Qin, Wei, et al.
Publicado: (2020)

UXT antisense RNA 1 sever as a novel prognostic long non-coding RNA in early stage pancreatic ductal adenocarcinoma patients after receiving pancreaticoduodenectomy
por: Liao, Xiwen, et al.
Publicado: (2021)

Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus‐related hepatocellular carcinoma
por: Yu, Tingdong, et al.
Publicado: (2017)

Marker of proliferation Ki-67 expression is associated with transforming growth factor beta 1 and can predict the prognosis of patients with hepatic B virus-related hepatocellular carcinoma
por: Yang, Chengkun, et al.
Publicado: (2018)

Observations and Experiments on Pus
por: Pearson, George
Publicado: (1811)

A Test for Pus
Publicado: (1872)

Palpation. Pus and Proteid
Publicado: (1907)

The Micrococcus of Bluish Pus
por: Van Peyma, P. W.
Publicado: (1880)

Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019)

Analysis of clinical significance and prospective molecular mechanism of main elements of the JAK/STAT pathway in hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2019)

Comprehensive investigation of key biomarkers and pathways in hepatitis B virus-related hepatocellular carcinoma
por: Liao, Xiwen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ohfi052ne79b8oapv3c7e5undl